Robert Burns
Stock Analyst at H.C. Wainwright
(4.82)
# 450
Out of 4,339 analysts
1006
Total ratings
48.1%
Success rate
19.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FATE Fate Therapeutics | Reiterated: Buy | $7 | $2.15 | +225.58% | 20 | May 26, 2026 | |
| RLAY Relay Therapeutics | Reiterated: Buy | $25 → $28 | $14.17 | +97.60% | 35 | May 26, 2026 | |
| NUVB Nuvation Bio | Reiterated: Buy | $17 | $4.69 | +262.47% | 32 | May 26, 2026 | |
| CRBU Caribou Biosciences | Maintained: Buy | $11 | $2.16 | +409.26% | 29 | May 26, 2026 | |
| BDTX Black Diamond Therapeutics | Reiterated: Buy | $11 | $2.33 | +372.10% | 41 | May 22, 2026 | |
| IMMX Immix Biopharma | Reiterated: Buy | $15 → $20 | $8.84 | +126.24% | 15 | May 22, 2026 | |
| CRDF Cardiff Oncology | Reiterated: Buy | $10 | $1.94 | +415.46% | 11 | May 15, 2026 | |
| AVBP ArriVent BioPharma | Reiterated: Buy | $44 | $27.94 | +57.48% | 17 | May 12, 2026 | |
| ZYME Zymeworks | Reiterated: Buy | $46 | $25.40 | +81.10% | 41 | May 11, 2026 | |
| ELVN Enliven Therapeutics | Reiterated: Buy | $56 | $42.53 | +31.67% | 11 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $15.46 | +94.05% | 8 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $54 → $56 | $49.98 | +12.04% | 24 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.47 | - | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $13 | $8.97 | +44.93% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $55 | $33.94 | +62.05% | 25 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $8.54 | +192.74% | 46 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.51 | +127.92% | 44 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $169 | $154.89 | +9.11% | 44 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $8.37 | +246.48% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $92.25 | +40.92% | 104 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 | $17.38 | +84.12% | 29 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $8 | $4.09 | +95.60% | 23 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $4.05 | +220.99% | 6 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.77 | - | 23 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $11 | $2.12 | +418.87% | 32 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $4.60 | - | 44 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $42 | $21.98 | +91.08% | 13 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $33 | $20.58 | +60.35% | 2 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $13 | $4.16 | +212.50% | 9 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $27 | $8.33 | +224.13% | 4 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $34 → $27 | $4.12 | +555.34% | 7 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $17 | $10.03 | +69.49% | 12 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $5.13 | +36.45% | 3 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $13 → $27 | $20.04 | +34.73% | 21 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.68 | +376.19% | 12 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.45 | +308.16% | 7 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.23 | +306.50% | 21 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.61 | - | 29 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $14.09 | n/a | 8 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0005 | n/a | 6 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.392 | n/a | 19 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $20 | $0.1772 | n/a | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.4518 | n/a | 13 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $27.10 | n/a | 18 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $5.76 | n/a | 7 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $3.69 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1.87 | n/a | 16 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.00 | n/a | 8 | Mar 5, 2021 |
Fate Therapeutics
May 26, 2026
Reiterated: Buy
Price Target: $7
Current: $2.15
Upside: +225.58%
Relay Therapeutics
May 26, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $14.17
Upside: +97.60%
Nuvation Bio
May 26, 2026
Reiterated: Buy
Price Target: $17
Current: $4.69
Upside: +262.47%
Caribou Biosciences
May 26, 2026
Maintained: Buy
Price Target: $11
Current: $2.16
Upside: +409.26%
Black Diamond Therapeutics
May 22, 2026
Reiterated: Buy
Price Target: $11
Current: $2.33
Upside: +372.10%
Immix Biopharma
May 22, 2026
Reiterated: Buy
Price Target: $15 → $20
Current: $8.84
Upside: +126.24%
Cardiff Oncology
May 15, 2026
Reiterated: Buy
Price Target: $10
Current: $1.94
Upside: +415.46%
ArriVent BioPharma
May 12, 2026
Reiterated: Buy
Price Target: $44
Current: $27.94
Upside: +57.48%
Zymeworks
May 11, 2026
Reiterated: Buy
Price Target: $46
Current: $25.40
Upside: +81.10%
Enliven Therapeutics
May 11, 2026
Reiterated: Buy
Price Target: $56
Current: $42.53
Upside: +31.67%
May 11, 2026
Reiterated: Buy
Price Target: $30
Current: $15.46
Upside: +94.05%
May 7, 2026
Reiterated: Buy
Price Target: $54 → $56
Current: $49.98
Upside: +12.04%
May 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.47
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: $8 → $13
Current: $8.97
Upside: +44.93%
May 6, 2026
Reiterated: Buy
Price Target: $52 → $55
Current: $33.94
Upside: +62.05%
May 5, 2026
Reiterated: Buy
Price Target: $25
Current: $8.54
Upside: +192.74%
May 5, 2026
Reiterated: Buy
Price Target: $8
Current: $3.51
Upside: +127.92%
May 4, 2026
Reiterated: Buy
Price Target: $169
Current: $154.89
Upside: +9.11%
May 1, 2026
Reiterated: Buy
Price Target: $29
Current: $8.37
Upside: +246.48%
Apr 27, 2026
Reiterated: Buy
Price Target: $130
Current: $92.25
Upside: +40.92%
Apr 27, 2026
Reiterated: Buy
Price Target: $32
Current: $17.38
Upside: +84.12%
Apr 27, 2026
Reiterated: Buy
Price Target: $5 → $8
Current: $4.09
Upside: +95.60%
Apr 22, 2026
Reiterated: Buy
Price Target: $13
Current: $4.05
Upside: +220.99%
Apr 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.77
Upside: -
Apr 16, 2026
Reiterated: Buy
Price Target: $8 → $11
Current: $2.12
Upside: +418.87%
Apr 13, 2026
Downgraded: Sell
Price Target: n/a
Current: $4.60
Upside: -
Mar 31, 2026
Reiterated: Buy
Price Target: $40 → $42
Current: $21.98
Upside: +91.08%
Mar 31, 2026
Reiterated: Buy
Price Target: $30 → $33
Current: $20.58
Upside: +60.35%
Mar 23, 2026
Reiterated: Buy
Price Target: $12 → $13
Current: $4.16
Upside: +212.50%
Mar 23, 2026
Reiterated: Buy
Price Target: $50 → $27
Current: $8.33
Upside: +224.13%
Mar 16, 2026
Maintained: Buy
Price Target: $34 → $27
Current: $4.12
Upside: +555.34%
Mar 13, 2026
Reiterated: Buy
Price Target: $13 → $17
Current: $10.03
Upside: +69.49%
Mar 13, 2026
Reiterated: Buy
Price Target: $7
Current: $5.13
Upside: +36.45%
Mar 6, 2026
Rated: Buy
Price Target: $13 → $27
Current: $20.04
Upside: +34.73%
Feb 13, 2026
Maintained: Buy
Price Target: $8
Current: $1.68
Upside: +376.19%
Feb 3, 2026
Reiterated: Buy
Price Target: $10
Current: $2.45
Upside: +308.16%
Nov 12, 2025
Reiterated: Buy
Price Target: $5
Current: $1.23
Upside: +306.50%
Aug 19, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.61
Upside: -
Sep 3, 2024
Rated: Hold
Price Target: n/a
Current: $14.09
Upside: n/a
Jul 16, 2024
Rated: Hold
Price Target: n/a
Current: $0.0005
Upside: n/a
May 24, 2024
Rated: Hold
Price Target: n/a
Current: $0.392
Upside: n/a
Mar 21, 2024
Reiterated: Buy
Price Target: $110 → $20
Current: $0.1772
Upside: n/a
Jan 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.4518
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $27.10
Upside: n/a
Mar 17, 2023
Reiterated: Buy
Price Target: $22
Current: $5.76
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $11
Current: $3.69
Upside: n/a
Oct 22, 2021
Maintained: Sell
Price Target: n/a
Current: $1.87
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $10
Current: $2.00
Upside: n/a